Estrogen Management
May help lower elevated estrogen levels when clinically appropriate.
Oral anastrozole treatment with licensed provider oversight and an individualized care plan.
Program PricingNot sold separately — included with select treatment programs.
Your provider will confirm whether it is part of your plan during your free consultation.
Start Your JourneyPrescription products require an online consultation with a licensed healthcare provider who will determine whether treatment is appropriate.
Anastrozole is an aromatase inhibitor that reduces estrogen production in the body. It is FDA-approved for certain breast cancer indications in postmenopausal women and may also be prescribed off-label to help manage elevated estrogen levels in select hormone therapy patients.
May help lower elevated estrogen levels when clinically appropriate.
May be considered alongside testosterone therapy when estrogen-related concerns require medical management.
Taken by mouth according to your provider’s instructions.
Treatment is based on hormone levels, symptoms, medical history, and clinical response.
Estrogen levels can be influenced by hormone therapy, medications, body composition, medical conditions, and other individual factors.
Patients with laboratory findings showing estrogen levels that may require clinical management.
Certain symptoms during hormone therapy may warrant evaluation of estrogen levels.
Anastrozole may be considered off-label when a provider determines estrogen management is medically appropriate.
Hormone levels and treatment response may require ongoing laboratory follow-up.
Symptoms alone do not establish an estrogen imbalance. A licensed healthcare provider will review your symptoms, medications, hormone levels, medical history, and individual risks before recommending treatment.
Anastrozole inhibits the aromatase enzyme, reducing the conversion of androgens into estrogens. When used as part of hormone therapy, treatment is individualized according to laboratory findings, symptoms, medical history, and response to treatment.
Anastrozole may cause side effects, and individual experiences can vary.
Lowering estrogen excessively may also cause unwanted symptoms and affect bone health. Your provider will review hormone levels, medications, medical history, and monitoring needs before and during treatment.
Share your medical history, current symptoms, medications, hormone therapy history, and health goals through our secure online assessment.
Meet remotely with a licensed healthcare provider who will review your information, laboratory results, and treatment options.
If treatment is prescribed, your medication and care plan will be coordinated through the appropriate licensed pharmacy, with ongoing provider oversight.
Discover other provider-guided treatments available through Premier Hormone Health.
Personalized hormone therapy guided by experienced providers.
Physician-guided plans for sustainable body composition improvement.
Provider-guided treatment options based on individual health needs.
Anastrozole may be obtained online with a valid prescription after an appropriate medical evaluation. A licensed healthcare provider must determine whether treatment is clinically appropriate.
An anastrozole prescription online begins with a provider evaluation. Your medical history, medications, symptoms, hormone levels when relevant, and potential risks are reviewed before a prescribing decision is made.
A lower dose such as anastrozole 0.5 mg may be prescribed when a provider determines that more individualized estrogen management is appropriate. The FDA-approved commercial anastrozole strength is a 1 mg tablet.
Anastrozole 0.25 mg refers to a lower dose that may be created through individualized dosing or a different formulation. It is not an FDA-approved commercial anastrozole strength, and Premier’s current public page does not list 0.25 mg as a standard option.
No. Anastrozole is FDA-approved for specific breast cancer indications in postmenopausal women. Its use to manage estrogen levels during testosterone or other hormone therapy is off-label.